Early research (Phase 1)Study completedNCT03846843What this trial is testingOCR002-SP103 - Oral Immediate Release StudyWho this might be right forCirrhosis Ocera Therapeutics, Inc. 30
Early research (Phase 1)Study completedNCT02286609What this trial is testingA Single Dose Evaluation of the Effects of Moderate Hepatic Impairment on Deflazacort PharmacokineticsWho this might be right forHepatic Impairment PTC Therapeutics 16
Early research (Phase 1)Study completedNCT01443481What this trial is testingPharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic FunctionWho this might be right forSolid TumorsHepatic Impairment Novartis Pharmaceuticals 38
Early research (Phase 1)Study completedNCT06485401What this trial is testingTo Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function SubjectsWho this might be right forInfluenza Type AInfluenza Type B Jiaxing AnDiCon Biotech Co.,Ltd 16
Large-scale testing (Phase 3)UnknownNCT04797884What this trial is testingElectromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma THERABIONIC INC. 166
Testing effectiveness (Phase 2)Study completedNCT01995071What this trial is testingEvaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)Who this might be right forChronic Hepatitis CHepatitis C VirusCompensated Cirrhosis AbbVie 89
Not applicableStudy completedNCT03534843What this trial is testingA Comparison Between Child-Pugh and Albumin-Bilirubin ScoresWho this might be right forRupture, SpontaneousRupture LiverHepatocellular Carcinoma+1 more Huazhong University of Science and Technology 230
Large-scale testing (Phase 3)UnknownNCT01854125What this trial is testingAutologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory AscitesWho this might be right forImmune Function in BloodLiver Function in BloodVariation of Ascites+2 more Nanjing PLA General Hospital 30
Not applicableActive Not RecruitingNCT06380335What this trial is testingStudy in Patients With Decompensated Liver CirrhosisWho this might be right forLiver Cirrhosis Resolution Therapeutics Limited 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05883644What this trial is testingDurvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)Who this might be right forAdvanced Hepatocellular Carcinoma AstraZeneca 111
Early research (Phase 1)Study completedNCT03092999What this trial is testingEffect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)Who this might be right forLeiomyoma Bayer 36
Testing effectiveness (Phase 2)Study completedNCT03211416What this trial is testingSorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver CancerWho this might be right forAdvanced Adult Hepatocellular CarcinomaChild-Pugh Class AStage III Hepatocellular Carcinoma+6 more Roswell Park Cancer Institute 37
Early research (Phase 1)Looking for participantsNCT06487559What this trial is testingAssess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)Who this might be right forHepatocellular Carcinoma (HCC) AbbVie 20
Testing effectiveness (Phase 2)Study completedNCT01232296What this trial is testingDovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line TreatmentWho this might be right forHepatocellular Carcinoma Novartis Pharmaceuticals 162
Early research (Phase 1)Study completedNCT05088642What this trial is testingA Trial of Hetrombopag in Healthy and Hepatic Impairment SubjectsWho this might be right forSever Aplastic Anaemia Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)Study completedNCT04971928What this trial is testingPhase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic ImpairmentWho this might be right forHepatitis B GlaxoSmithKline 24
Early research (Phase 1)Study completedNCT01289951What this trial is testingPharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic CirrhosisWho this might be right forHuman Immunodeficiency VirusHepatitis C Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07219459What this trial is testingVisugromab, Nivolumab and a Tyrosine Kinase Inhibitor (TKI) Compared to Double Placebo and a TKI in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 FailureWho this might be right forUnresectable or Metastatic Hepatocellular CarcinomaFailure of First-Line Treatment That Included an Anti PD-(L)1 CompoundChild-Pugh A Hepatocellular Carcinoma CatalYm GmbH 104
Testing effectiveness (Phase 2)Ended earlyNCT01097083What this trial is testingCoriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular CarcinomaWho this might be right forCarcinomaTherapy National University Hospital, Singapore 20
Early research (Phase 1)Study completedNCT02857868What this trial is testingA Trial to Evaluate the Pharmacokinetics of ABL001 in Healthy and Hepatic Impaired SubjectsWho this might be right forHepatic Impairment Novartis Pharmaceuticals 32